Stay updated on Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial

Sign up to get notified when there's something new on the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision history shows a new revision v3.5.0 added and an older revision v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-19T06:12:56.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The revision history shows a new entry for v3.4.3 added and the previous v3.4.2 entry removed.
    Difference
    0.1%
    Check dated 2026-03-12T02:37:33.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history; removed the funding notice and the earlier Revision: v3.4.1.
    Difference
    1.0%
    Check dated 2026-02-11T12:34:22.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Added a Notice about a lapse in government funding stating that information may not be up to date and directing users to status sources. Updated the page revision to v3.4.1 and removed the previous v3.4.0 entry.
    Difference
    1.0%
    Check dated 2026-02-04T06:52:55.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page now shows a glossary toggle and introduces color-coded highlights (green for additions, red for deletions) in the history view, along with a revision note updated to v3.4.0 and minor wording changes such as capitalization of 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-28T04:31:44.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The history now shows a new revision entry v3.3.4 and the removal of v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:36:37.000Z thumbnail image

Stay in the know with updates to Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page.